These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 25724294)

  • 1. High doses of onabotulinumtoxinA in post-stroke spasticity: a retrospective analysis.
    Baricich A; Grana E; Carda S; Santamato A; Cisari C; Invernizzi M
    J Neural Transm (Vienna); 2015 Sep; 122(9):1283-7. PubMed ID: 25724294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of treatment with incobotulinum toxin A (botulinum neurotoxin type A free from complexing proteins; NT 201) in post-stroke upper limb spasticity.
    Kaňovský P; Slawek J; Denes Z; Platz T; Comes G; Grafe S; Pulte I
    J Rehabil Med; 2011 May; 43(6):486-92. PubMed ID: 21533328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, double-blind, placebo-controlled, dose-ranging study to compare the efficacy and safety of three doses of botulinum toxin type A (Dysport) with placebo in upper limb spasticity after stroke.
    Bakheit AM; Thilmann AF; Ward AB; Poewe W; Wissel J; Muller J; Benecke R; Collin C; Muller F; Ward CD; Neumann C
    Stroke; 2000 Oct; 31(10):2402-6. PubMed ID: 11022071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High doses of incobotulinumtoxinA for the treatment of post-stroke spasticity: are they safe and effective?
    Santamato A; Ranieri M; Solfrizzi V; Lozupone M; Vecchio M; Daniele A; Greco A; Seripa D; Logroscino G; Panza F
    Expert Opin Drug Metab Toxicol; 2016 Aug; 12(8):843-6. PubMed ID: 27291256
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy and Safety of OnabotulinumtoxinA 400 Units in Patients with Post-Stroke Upper Limb Spasticity: Final Report of a Randomized, Double-Blind, Placebo-Controlled Trial with an Open-Label Extension Phase.
    Abo M; Shigematsu T; Hara H; Matsuda Y; Nimura A; Yamashita Y; Takahashi K
    Toxins (Basel); 2020 Feb; 12(2):. PubMed ID: 32085529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term safety of repeated high doses of incobotulinumtoxinA injections for the treatment of upper and lower limb spasticity after stroke.
    Santamato A; Panza F; Intiso D; Baricich A; Picelli A; Smania N; Fortunato F; Seripa D; Fiore P; Ranieri M
    J Neurol Sci; 2017 Jul; 378():182-186. PubMed ID: 28566161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin type A in post-stroke upper limb spasticity.
    Kaji R; Osako Y; Suyama K; Maeda T; Uechi Y; Iwasaki M;
    Curr Med Res Opin; 2010 Aug; 26(8):1983-92. PubMed ID: 20569068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, double-blind, placebo-controlled study of the efficacy and safety of botulinum toxin type A in upper limb spasticity in patients with stroke.
    Bakheit AM; Pittock S; Moore AP; Wurker M; Otto S; Erbguth F; Coxon L
    Eur J Neurol; 2001 Nov; 8(6):559-65. PubMed ID: 11784339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin injection for hypertonicity of the upper extremity within 12 weeks after stroke: a randomized controlled trial.
    Rosales RL; Kong KH; Goh KJ; Kumthornthip W; Mok VC; Delgado-De Los Santos MM; Chua KS; Abdullah SJ; Zakine B; Maisonobe P; Magis A; Wong KS
    Neurorehabil Neural Repair; 2012 Sep; 26(7):812-21. PubMed ID: 22371239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind randomised placebo-controlled evaluation of three doses of botulinum toxin type A (Dysport) in the treatment of spastic equinovarus deformity after stroke.
    Pittock SJ; Moore AP; Hardiman O; Ehler E; Kovac M; Bojakowski J; Al Khawaja I; Brozman M; Kanovský P; Skorometz A; Slawek J; Reichel G; Stenner A; Timerbaeva S; Stelmasiak Z; Zifko UA; Bhakta B; Coxon E
    Cerebrovasc Dis; 2003; 15(4):289-300. PubMed ID: 12686794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The beneficial antispasticity effect of botulinum toxin type A is maintained after repeated treatment cycles.
    Bakheit AM; Fedorova NV; Skoromets AA; Timerbaeva SL; Bhakta BB; Coxon L
    J Neurol Neurosurg Psychiatry; 2004 Nov; 75(11):1558-61. PubMed ID: 15489387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin type A for upper limb spasticity following stroke: an open-label study with individualised, flexible injection regimens.
    Slawek J; Bogucki A; Reclawowicz D
    Neurol Sci; 2005 Apr; 26(1):32-9. PubMed ID: 15877185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of botulinum toxin A in upper limb function of hemiplegic patients.
    Rousseaux M; Kozlowski O; Froger J
    J Neurol; 2002 Jan; 249(1):76-84. PubMed ID: 11954872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke.
    Brashear A; Gordon MF; Elovic E; Kassicieh VD; Marciniak C; Do M; Lee CH; Jenkins S; Turkel C;
    N Engl J Med; 2002 Aug; 347(6):395-400. PubMed ID: 12167681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of botulinum neurotoxin NT 201 in poststroke upper limb spasticity.
    Kanovský P; Slawek J; Denes Z; Platz T; Sassin I; Comes G; Grafe S
    Clin Neuropharmacol; 2009; 32(5):259-65. PubMed ID: 19644361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of NABOTA in post-stroke upper limb spasticity: a phase 3 multicenter, double-blinded, randomized controlled trial.
    Nam HS; Park YG; Paik NJ; Oh BM; Chun MH; Yang HE; Kim DH; Yi Y; Seo HG; Kim KD; Chang MC; Ryu JH; Lee SU
    J Neurol Sci; 2015 Oct; 357(1-2):192-7. PubMed ID: 26233808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can botulinum toxin type A injection technique influence the clinical outcome of patients with post-stroke upper limb spasticity? A randomized controlled trial comparing manual needle placement and ultrasound-guided injection techniques.
    Santamato A; Micello MF; Panza F; Fortunato F; Baricich A; Cisari C; Pilotto A; Logroscino G; Fiore P; Ranieri M
    J Neurol Sci; 2014 Dec; 347(1-2):39-43. PubMed ID: 25263601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin as early intervention for spasticity after stroke or non-progressive brain lesion: A meta-analysis.
    Rosales RL; Efendy F; Teleg ES; Delos Santos MM; Rosales MC; Ostrea M; Tanglao MJ; Ng AR
    J Neurol Sci; 2016 Dec; 371():6-14. PubMed ID: 27871449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of botulinum toxin type A for upper limb spasticity after stroke or traumatic brain injury: a systematic review with meta-analysis and trial sequential analysis.
    Dong Y; Wu T; Hu X; Wang T
    Eur J Phys Rehabil Med; 2017 Apr; 53(2):256-267. PubMed ID: 27834471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How could robotic training and botolinum toxin be combined in chronic post stroke upper limb spasticity? A pilot study.
    Pennati GV; Da Re C; Messineo I; Bonaiuti D
    Eur J Phys Rehabil Med; 2015 Aug; 51(4):381-7. PubMed ID: 25358636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.